Hawryluk Matthew 4
4 · Gritstone Oncology, Inc. · Filed Mar 14, 2019
Insider Transaction Report
Form 4
Hawryluk Matthew
EVP, CHIEF BUSINESS OFFICER
Transactions
- Award
Stock Option (Right to Buy)
[F1]2019-02-13+55,000→ 55,000 totalExercise: $12.02From: 2019-04-01Exp: 2029-02-12→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on March 1, 2019.
Signature
/s/ Dana B. Johnson, Attorney-in-Fact for Matthew Hawryluk|2019-03-14